Skip to main content
. 2022 Feb 14;10(2):437. doi: 10.3390/biomedicines10020437

Figure 1.

Figure 1

FDA timeline of antivirals approval and EUAs. Veklury® EUA was formalized in January 2020. Its definitive approval occurred in October 2020. Molnupinavir and Paxlovid® EUAs followed in December 2021. Indications are also presented, in gray-outlined boxes, on the side of each authorized therapeutic agent. Abbreviations. FDA: Food and Drug Administration; EUA: Emergency Use Authorization.